|
Currently Available Assays
|
Syncitium International is strongly committed to fully investigate and understand the potential value of genotyping in improving the safety and efficacy of cancer therapy
|
Syncitium International Central Lab Provides pharmacogenetic Testing for Cancer Therapy
|
|
For
§ Pharmacogenomic Screening of patients enrolled in clinical trials
§ Genetic polymorphism involved in safety and/or efficacy of drugs
§ SNP determination
§ Pharmacogenomic profiling
|
Quality Service
|
|
§ Adherence to study plan
§ Sample handling/storage compliant with Good Laboratory Practices
§ Complete transparency in experimental execution MIAME / MGED guidelines
§ Full traceability from simple receipt to final report
§ Data archiving
|
|
